FDA Clears First BAFF/APRIL Blocker for Kidney Disease Linked to Autoimmunity
<p>The FDA granted accelerated approval to atacicept (Trutakna) for primary IgA nephropathy, the first therapy to block two key immune signa...
Read More — FDA Clears First BAFF/APRIL Blocker for Kidney Disease Linked to Autoimmunity »